Editor in Chief's Call for Papers

Dear colleague,

As Editor in Chief I thank you for your interest in Translational Oncogenomics, an international, peer reviewed open access journal focussing on all aspects of  this important subject.

As Editor in Chief I work closely with the publisher, Libertas, to deliver what I consider to be amongst the best scholarly publishing available from any journal:

• Convenient 3-step online manuscript submission

• No space restrictions or color figure charges

• Optional immediate publication on acceptance

• Inclusion in an expanding selection of high-visibility indexes, directories, and social media channels

• Research freely available to distribute and compliance with open access mandates

• High readership and impact

• Fast constructive peer review

• Professional author service

Translational Oncogenomics is designed to provide high visibility to your paper.  The Article Views figure above shows the total quantity of views of journal articles.  To maximise your paper’s visibility the publisher works intensively on search engine optimisation and your article will be announced on Twitter, RSS, LinkedIn and email newsletters.  The journal is extensively indexed, including Pubmed, and the publisher adds the journal to new indexes as it becomes eligible.

When your submission is received it will be subject to an initial assessment to ensure it is ready for peer review.  After peer review is completed an editorial decision will be made on its suitability for publication on the basis of two peer review reports.  Following final acceptance Libertas’ efficient and user-friendly interface will guide you through the production process.  Your paper will be published as soon as it is ready.  If you need it, copy editing, figure creation and provisional PDF publication is available.

Submit your paper whenever you wish.  The submission process takes less than two minutes and processing will commence on the same day.  Click here to commence the submission process now.

Yours sincerely,

Dr Michael Spinella

Editor-in-Chief

Translational Oncogenomics